Gibbs Cancer Center and Research

Spartanburg Medical Center

Spartanburg, SC

Sorting 3 by

Accepting patients

SubQSA

A Single-arm, Open-label, Phase 2 Study Evaluating Subcutaneous Administration of Isatuximab, Administered by an On Body Delivery System, in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)
Learn more
  • Monoclonal Antibody
  • CD38
  • Phase 2

Not yet accepting

MajesTEC-4

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4
Learn more
  • Bispecific Antibody
  • Bispecific T Cell Engager (BiTE)
  • BCMA
  • Phase 3

Accepting patients

Early Detection Blood Tests

Blinded Reference Set for Multicancer Early Detection Blood Tests
Learn more
  • Observational Trial